SEARCH

SEARCH BY CITATION

References

  • 1
    Olesen C, Steffensen FH, Nielsen GL, de Jong-van den Berg, Olsen J, Sorensen HT. Drug use in first pregnancy and lactation: a population-based survey among Danish women. The EUROMAP group. Eur J Clin Pharmacol 1999;55: 13944.
  • 2
    Lacroix I, Damase-Michel C, Lapeyre-Mestre M, Montastruc JL. Prescription of drugs during pregnancy in France. Lancet 2000;356: 17356.
  • 3
    Donati S, Baglio G, Spinelli A, Grandolfo ME. Drug use in pregnancy among Italian women. Eur J Clin Pharmacol 2000;56: 3238.
  • 4
    Egen-Lappe V, Hasford J. Drug prescription in pregnancy: analysis of a large statutory sickness fund population. Eur J Clin Pharmacol 2004;60: 65966.
  • 5
    Nordeng H, Eskild A, Nesheim BI, Jacobsen G. Drug use in pregnancy among parous Scandinavian women. N J Epidem 2001;11: 97103.
  • 6
    Schirm E, Meijer WM, Tobi H, De Jong-van den Berg LT. Drug use by pregnant women and comparable non-pregnant women in The Netherlands with reference to the Australian classification system. Eur J Obstet Gynecol Reprod Biol 2004;114: 1828.
  • 7
    De Jong-van den Berg LT, Van Den Berg PB, Haaijer-Ruskamp FM, Dukes MN, Wesseling H. Investigating drug use in pregnancy. Methodological problems and perspectives. Pharm Weekbl Sci 1991;13: 328.
  • 8
    Wiebe S. Managing women with epilepsy. Guideline producers now need to pay attention to implementation. BMJ 2000;320: 34.
  • 9
    Moore TR. Diabetes in pregnancy. In: CreasyRK, ResnikR, editors. Maternal-Fetal Medicine. Philadelphia, PA: Saunders; 1999. p. 96495.
  • 10
    Tobi H, Van Den Berg PB, De Jong-van den Berg LTW. The Interaction Database: synergy of science and practice in pharmacy. In: BrauseRW, HanischE, editors. Medical Data Analysis. Berlin, Germany: Springer-Verlag; 2000. p. 20611.
  • 11
    Schirm E, Monster TB, De Vries R, Van Den Berg PB, De Jong-van den Berg LT, Tobi H. How to estimate the population that is covered by community pharmacies? An evaluation of two methods using drug utilisation information. Pharmacoepidemiol Drug Saf 2004;13: 1739.
  • 12
    WHO Collaborating Centre for Drugs Statistics Methodology. ATC/DDD Index 2004 [www.whocc.no/atcddd/]. Accessed 2 December 2004.
  • 13
    Leufkens HGM, Urquhart J. Automated pharmacy record linkage in the Netherlands. In: StromBL, editor. Pharmacoepidemiology. Chichester, UK: John Wiley & Sons; 2000. p. 34760.
  • 14
    Schirm E, Tobi H, De Jong-van den Berg LT. Identifying parents in pharmacy data: a tool for the continuous monitoring of drug exposure to unborn children. J Clin Epidemiol 2004; 57: 73741.
  • 15
    Medicines in Pregnancy Working Party of the Australian Drug Evaluation Committee. Prescribing medicines in pregnancy. An Australian categorisation of risk of drug use in pregnancy, 4th edn. 1999 [www.tga.gov.au/docs/html/medpreg.htm] Accessed 12 January 2003.
  • 16
    De Jong PC, Nijdam WS, Zielhuis GA, Eskes TK. Medication during low-risk pregnancy. Eur J Obstet Gynecol Reprod Biol 1991;41: 1916.
  • 17
    Malm H, Martikainen J, Klaukka T, Neuvonen PJ. Prescription drugs during pregnancy and lactation—a Finnish register-based study. Eur J Clin Pharmacol 2003;59: 12733.
  • 18
    Andrade SE, Gurwitz JH, Davis RL, Chan KA, Finkelstein JA, Fortman K, et al. Prescription drug use in pregnancy. Am J Obstet Gynecol 2004;191: 398407.
  • 19
    Chun-Fai-Chan B, Koren G, Fayez I, Kalra S, Voyer-Lavigne S, Boshier A, et al. Pregnancy outcome of women exposed to bupropion during pregnancy: a prospective comparative study. Am J Obstet Gynecol 2005;192: 9326.
  • 20
    Simon GE, Cunningham ML, Davis RL. Outcomes of prenatal antidepressant exposure. Am J Psychiatry 2002;159: 205561.
  • 21
    Ostensen M, Villiger PM. Immunology of pregnancy—pregnancy as a remission inducing agent in rheumatoid arthritis. Transpl Immunol 2002;9: 15560.
  • 22
    Olesen C, Sorensen HT, De Jong-van den Berg, Olsen J, Steffensen FH. Prescribing during pregnancy and lactation with reference to the Swedish classification system. A population-based study among Danish women. The Euromap Group. Acta Obstet Gynecol Scand 1999;78: 68692.
  • 23
    Raebel MA, Ellis JL, Andrade SE. Evaluation of gestational age and admission date assumptions used to determine prenatal drug exposure from administrative data. Pharmacoepidemiol Drug Saf 2005;14: 82936.
  • 24
    Olesen C, Sondergaard C, Thrane N, Nielsen GL, de Jong-van den Berg, Olsen J. Do pregnant women report use of dispensed medications? Epidemiology 2001;12: 497501.
  • 25
    Werler MM, Mitchell AA, Hernandez-Diaz S, Honein MA. Use of over-the-counter medications during pregnancy. Am J Obstet Gynecol 2005;193: 7717.
  • 26
    Shaheen SO, Newson RB, Sherriff A, Henderson AJ, Heron JE, Burney PG, et al. Paracetamol use in pregnancy and wheezing in early childhood. Thorax 2002;57: 95863.